Immunorecognition of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Some Normal and Malignant Tissues from Genitourinary System

Table 3

Immunorecognition of 14F7 Mab in primary tumors of female genital system.

Histopathological type	No of cases (%)	Intensity range	Positive cells
Breast	41/42 (97.6)
(i) Infiltrating ductal carcinoma	32/32 (100)
(a) NOS	12/12	+/+++	3
(b) Papillary carcinoma	4/4	+++	3
(c) Medullary carcinoma	10/10	+/++/+++	3
(d) Metaplastic carcinoma	2/2	+++	3
(e) Mucinous carcinoma	2/2	+/++	3
(f) Tubular carcinoma	1/1	+++	3
(g) Pleomorphic carcinoma	1/1	+++	3
(ii) Infiltrating lobular carcinoma	9/10 (90)	+/++/+++	3
Ovary	22/35 (62.8)
(i) Cystadenocarcinoma	21/34 (61.8)
Serous	8/12 (66.6)	++/+++	3
Mucinous	7/9 (77.7)	+++	3
Seromucinous	0/1	−	0
Endometrioid	5/11 (44.5)	++/+++	1/3
(ii) Neuroendocrine tumor	1/1	++	3
Uterus	5/14 (35.7)
(i) Corpus (endometrial carcinoma)	4/7 (57.1)
Well differentiated	3/3	++/+++	3
Moderate differentiated	1/1	+++	3
Poorly differentiated	0/3	−	0
(ii) Cervix (carcinoma)	1/7 (14.3)
in situ	0/2	−	0
Well differentiated	0/4	−	0
Poorly differentiated	1/1	+/++	2

NOS, Not otherwise specified. Intensity: −: negative, ++: moderate, +++: intense. Positive cells: 0 (negative to less than 5%), 1 (6–25%), 2 (26–50%), and 3 (more than 50%).